Project Details
Description
COG Study: AAML1831 – A Collaboration between COG, Jazz Pharmaceuticals, Astellas Pharma Global Development, Inc., and Foundation Medicine, Inc.
Status | Finished |
---|---|
Effective start/end date | 12/20/21 → 2/28/22 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- VARIOUS SPONSORS - NON-FEDERAL
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.